Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Coatings TrendsCoatings Trends
Not Confirmed
Not Confirmed
03-05 September, 2025
Not Confirmed
Not Confirmed
04-06 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Coatings TrendsCoatings Trends
Industry Trade Show
Not Confirmed
03-05 September, 2025
Industry Trade Show
Not Confirmed
04-06 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
20 Aug 2025
// ECONOMICTIMES
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/aurobindo-leads-race-for-5-5-bn-zentiva-deal-set-to-be-indias-biggest-pharma-buyout/articleshow/123394210.cms
09 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/zentiva-and-lupin-sign-license-and-supply-agreement-for-tnf-alpha-inhibitor-biosimilar-medicine-302501088.html
27 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/zentiva-calls-for-pause--repair--relaunch-of-the-urban-wastewater-treatment-directive-uwwtd-302493177.html
22 May 2025
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/zentiva-inks-deal-worth-eu220m-commercialize-former-astrazeneca-gi-asset-europe
22 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/zentiva-and-euractiv-bring-policymakers-together-for-health-policy-conference-302463025.html
07 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/zentiva-joins-the-call-to-action-to-finalize-pharmaceutical-reform-and-secure-sustainable-healthcare-for-people-in-europe-302448717.html
Details:
Under the licensing agreement, Zentiva will hold the rights for the commercialization and manufacturing of linaprazan glurate, in Europe.
Lead Product(s): Linaprazan Glurate,Inapplicable
Therapeutic Area: Gastroenterology Brand Name: Undisclosed
Study Phase: Phase IIProduct Type: Other Small Molecule
Recipient: Cinclus Pharma
Deal Size: $249.2 million Upfront Cash: $14.7 million
Deal Type: Licensing Agreement May 22, 2025
Lead Product(s) : Linaprazan Glurate,Inapplicable
Therapeutic Area : Gastroenterology
Highest Development Status : Phase II
Recipient : Cinclus Pharma
Deal Size : $249.2 million
Deal Type : Licensing Agreement
Zentiva Inks €220M Deal for Former AstraZeneca GI Drug in Europe
Details : Under the licensing agreement, Zentiva will hold the rights for the commercialization and manufacturing of linaprazan glurate, in Europe.
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : $14.7 million
May 22, 2025
Details:
Raltegravir is an approved, small molecule, HIV-1 integrase inhibitor, available as a film coated tablet for the treatment of HIV in adult and paediatric patients weighing at least 40kg.
Lead Product(s): Raltegravir Potassium,Inapplicable
Therapeutic Area: Infections and Infectious Diseases Brand Name: Raltegravir-Generic
Study Phase: Approved FDFProduct Type: Other Small Molecule
Recipient: Lupin Ltd
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable July 22, 2024
Lead Product(s) : Raltegravir Potassium,Inapplicable
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved FDF
Recipient : Lupin Ltd
Deal Size : Inapplicable
Deal Type : Inapplicable
Generic HIV raltegravir medicines approved
Details : Raltegravir is an approved, small molecule, HIV-1 integrase inhibitor, available as a film coated tablet for the treatment of HIV in adult and paediatric patients weighing at least 40kg.
Product Name : Raltegravir-Generic
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 22, 2024
Details:
Liraglutide-Generic is a glucagon-like peptide-1 (GLP-1) receptor agonist, which is indicated for the treatment of patients with type 2 diabetes mellitus.
Lead Product(s): Liraglutide,Inapplicable
Therapeutic Area: Endocrinology Brand Name: Liraglutide-Generic
Study Phase: Approved FDFProduct Type: Peptide
Recipient: Biocon
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable March 28, 2024
Lead Product(s) : Liraglutide,Inapplicable
Therapeutic Area : Endocrinology
Highest Development Status : Approved FDF
Recipient : Biocon
Deal Size : Inapplicable
Deal Type : Inapplicable
Biocon to Obtain Approval for Diabetes Drug, Liraglutide in UK
Details : Liraglutide-Generic is a glucagon-like peptide-1 (GLP-1) receptor agonist, which is indicated for the treatment of patients with type 2 diabetes mellitus.
Product Name : Liraglutide-Generic
Product Type : Peptide
Upfront Cash : Inapplicable
March 28, 2024
Details:
Under the terms of collaboration, Zentiva will complement their product offering with the support of longstanding partners Adalvo with new molecules in a variety of therapeutical areas like Respiratory, CNS and Dermatology.
Lead Product(s): Undisclosed,Inapplicable
Therapeutic Area: Pulmonary/Respiratory Diseases Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Undisclosed
Recipient: Adalvo
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Expanded Collaboration September 01, 2023
Lead Product(s) : Undisclosed,Inapplicable
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Undisclosed
Recipient : Adalvo
Deal Size : Undisclosed
Deal Type : Expanded Collaboration
Details : Under the terms of collaboration, Zentiva will complement their product offering with the support of longstanding partners Adalvo with new molecules in a variety of therapeutical areas like Respiratory, CNS and Dermatology.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
September 01, 2023
Details:
Through this acquisition, Zentiva will significantly increase its position in the Hospital sector and more specifically in the Oncology area with some value-added 16 products complementing the products recently launched.
Lead Product(s): Undisclosed,Inapplicable
Therapeutic Area: Oncology Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Undisclosed
Recipient: Tillomed Laboratories Ltd
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Acquisition December 16, 2022
Lead Product(s) : Undisclosed,Inapplicable
Therapeutic Area : Oncology
Highest Development Status : Undisclosed
Recipient : Tillomed Laboratories Ltd
Deal Size : Undisclosed
Deal Type : Acquisition
Zentiva Completes Major Product Acquisition from Tillomed Spain
Details : Through this acquisition, Zentiva will significantly increase its position in the Hospital sector and more specifically in the Oncology area with some value-added 16 products complementing the products recently launched.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
December 16, 2022
Details:
Under the terms of this agreement Biocon will be responsible for the manufacturing and supply of Liraglutide to Zentiva, for its commercialization across 30 countries in Europe.
Lead Product(s): Liraglutide,Inapplicable
Therapeutic Area: Endocrinology Brand Name: Liraglutide-Generic
Study Phase: UndisclosedProduct Type: Peptide
Recipient: Biocon
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement November 23, 2022
Lead Product(s) : Liraglutide,Inapplicable
Therapeutic Area : Endocrinology
Highest Development Status : Undisclosed
Recipient : Biocon
Deal Size : Undisclosed
Deal Type : Agreement
Biocon Limited Enters Into a Commercialization Agreement With Zentiva in Europe
Details : Under the terms of this agreement Biocon will be responsible for the manufacturing and supply of Liraglutide to Zentiva, for its commercialization across 30 countries in Europe.
Product Name : Liraglutide-Generic
Product Type : Peptide
Upfront Cash : Undisclosed
November 23, 2022
Details:
Alymsys (bevacizumab-maly) is a vascular endothelial growth factor inhibitor for the treatment of metastatic colorectal cancer, in combination with intravenous fluorouracil-based chemotherapy for first or second-line treatment.
Lead Product(s): Bevacizumab,Fluorouracil,Calcium Folinate
Therapeutic Area: Oncology Brand Name: Alymsys
Study Phase: Approved FDFProduct Type: Antibody
Recipient: Mabxience
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Collaboration September 04, 2021
Lead Product(s) : Bevacizumab,Fluorouracil,Calcium Folinate
Therapeutic Area : Oncology
Highest Development Status : Approved FDF
Recipient : Mabxience
Deal Size : Undisclosed
Deal Type : Collaboration
Zentiva Continues Its Expansion in Oncology with The Launch of Alymsys® (Bevacizumab) in 21 Count...
Details : Alymsys (bevacizumab-maly) is a vascular endothelial growth factor inhibitor for the treatment of metastatic colorectal cancer, in combination with intravenous fluorouracil-based chemotherapy for first or second-line treatment.
Product Name : Alymsys
Product Type : Antibody
Upfront Cash : Undisclosed
September 04, 2021
Details:
Mithra grants license to Zentiva for commercialization of its vaginal contraceptive ring in three key European markets.
Lead Product(s): Etonogestrel,Ethinyl Estradiol
Therapeutic Area: Obstetrics/Gynecology (Women’s Health) Brand Name: Myring
Study Phase: Approved FDFProduct Type: Hormone
Recipient: Mithra Pharmaceuticals
Deal Size: $2.2 million Upfront Cash: Undisclosed
Deal Type: Agreement June 07, 2020
Lead Product(s) : Etonogestrel,Ethinyl Estradiol
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Approved FDF
Recipient : Mithra Pharmaceuticals
Deal Size : $2.2 million
Deal Type : Agreement
Mithra to Commercialize Myring In France, Poland And UK
Details : Mithra grants license to Zentiva for commercialization of its vaginal contraceptive ring in three key European markets.
Product Name : Myring
Product Type : Hormone
Upfront Cash : Undisclosed
June 07, 2020
Details:
Undisclosed
Lead Product(s): Abiraterone Acetate,Inapplicable
Therapeutic Area: Undisclosed Brand Name: Undisclosed
Study Phase: Phase IProduct Type: Other Small Molecule
Sponsor: Inapplicable
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable March 04, 2020
Lead Product(s) : Abiraterone Acetate,Inapplicable
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study Designed to Evaluate the Pharmacokinetic Profile of Abiraterone
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 04, 2020
Regulatory Info :
Registration Country : Italy
Dosage Form : Gastro-Resistant Tablets
Dosage Strength : 100 mg
Packaging : 30 UNITS 100 MG - ...
Brand Name : ACETYLSALICYLIC ACID ZENTIVA ...
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Dosage Form : Tablets
Dosage Strength : 200 mg
Packaging : 25 UNITS 200 MG - ...
Brand Name : ACICLOVIR ZENTIVA ITALY
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Dosage Form : Tablets
Dosage Strength : 400 mg
Packaging : 25 UNITS 400 MG - ...
Brand Name : ACICLOVIR ZENTIVA ITALY
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Dosage Form : Tablets
Dosage Strength : 800 mg
Packaging : 35 UNITS 800 MG - ...
Brand Name : ACICLOVIR ZENTIVA ITALY
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Dosage Form : Alendronic Acid 70Mg 4 Units' ...
Dosage Strength : 4 CPR 70 mg
Packaging :
Brand Name : Alendronic Acid
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Dosage Form : Tablets
Dosage Strength : 70 mg
Packaging : 4 UNITS 70 MG - OR...
Brand Name : ALENDRONIC ACID ZENTIVA
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Alendronic acid; Cholecalciferol
Dosage Form : Tablets
Dosage Strength : 70 mg/2,800 iu
Packaging : 4 UNITS 70 MG/2800...
Brand Name : ALENDRONIC ACID AND CHOLECALC...
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Alendronic acid; Cholecalciferol
Dosage Form : Tablets
Dosage Strength : 70 mg/5,600 iu
Packaging : 4 UNITS 70 MG/5600...
Brand Name : ALENDRONIC ACID AND CHOLECALC...
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Dosage Form : Alfuzosina 10Mg 30 Joined' Ora...
Dosage Strength : 30 CPR 10 mg prolonged rele...
Packaging :
Brand Name : Alfuzina
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Dosage Form : Extended Release Tablets
Dosage Strength : 10 mg
Packaging : 30 UNITS 10 MG - O...
Brand Name : ALFUZOSIN ZENTIVA
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
REF. STANDARDS & IMPURITIES
Inspections and registrations
ABOUT THIS PAGE
Zentiva is a supplier offers 18 products (APIs, Excipients or Intermediates).
Find a price of Articaine Hydrochloride bulk with DMF, CEP, WC offered by Zentiva
Find a price of Glibenclamide bulk with DMF, CEP, WC offered by Zentiva
Find a price of Pentoxifylline bulk with CEP, WC offered by Zentiva
Find a price of Tamsulosin bulk with CEP, WC offered by Zentiva
Find a price of Agomelatine bulk with WC offered by Zentiva
Find a price of Glibenclamide bulk with WC offered by Zentiva
Find a price of Pheniramine Maleate bulk with WC offered by Zentiva
Find a price of Ramipril bulk with WC offered by Zentiva
Find a price of Rilmenidine Phosphate bulk with CEP offered by Zentiva
Find a price of Tamsulosin bulk with CEP offered by Zentiva
Find a price of Tenofovir Alafenamide bulk with WC offered by Zentiva
Find a price of Carvedilol bulk offered by Zentiva
Find a price of Glimepiride bulk offered by Zentiva
Find a price of Metipranolol HCl bulk offered by Zentiva
Find a price of Metoprolol Succinate bulk offered by Zentiva
Find a price of Tetrahydrozoline bulk offered by Zentiva
Find a price of Tramadol Hydrochloride bulk offered by Zentiva
Find a price of Zolpidem Tartrate bulk offered by Zentiva